Global Topical Use Acne Treatment Market, According to Data Bridge Market Research new Market report, “By Drug Class (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, Topical Retinoid), By Route of Administration (Topical, Oral), By Product Type (Prescription, OTC), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 7.66 billion by 2025, at a CAGR of 5.1% during the forecast period of 2018 to 2025.
Get 10% discount on this report to request a free sample copy or view summary of this report, click the link below @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-use-acne-treatment-market
Global Topical Use Acne Treatment Market
Acne is an inflammatory skin situation, which creates pimples and spots, especially on the sensitive areas such as face, neck, shoulders, upper arms, back, and chest. The condition affects 3 in every 4 persons aged 11 to 30 years. More than 90 percent of world population is affected by acne at some point in their life. Although acne is a skin disease, it can lead to prominent emotional and psychological issues. Various studies have confirmed that, a person’s quality of life, self-esteem, and mood can be affected by acne. Acne is a chronic, inflammatory skin condition with a multifactorial pathogenesis. The cause of acne is due to hormonal changes during puberty and it is then further aggravated by genetic and other factors.
Topical acne treatments are creams, gels, or lotions that you apply directly to your skin. Benzoyl peroxide is an inexpensive, over-the-counter product that you can use to treat milder forms of acne.
In July 2016 the U.S. food and drug administration approved Differin Gel 0.1%, which is first in a class of drugs known as retinoids to be made available OTC for the treatment of acne, and contains the first new active ingredient for acne treatment for OTC use since the 1980s. Differin Gel 0.1% is approved for use in people 12 years of age and older.
According to a study published in retinoid education week in March 2018, it was found out that retinoids is one of the most effective ingredients available to treat acne. It was available to consumers only by prescription until last year but is now widely available over-the-counter.
For Customized Reports and Discounts, Mail us @ email@example.com
Note: If you have any special requirements, please let us know and we will offer you the report as you want.
Segmentation: Global Topical Use Acne Treatment Market
The global market for topical use acne by the following sub-categories is presented
By Product Type
By Drug Class
- Anti-Inflammatory Drugs
- Combination Medications
- Hormonal Agents
- Oral Retinoid
- Topical Retinoid
By Route of Administration
- North America
- South America
- Middle East and Africa
FACTORS DRIVING GROWTH OF GLOBAL TOPICAL USE ACNE TREATMENT MARKET
Increase in global prevalence rate of acne:
According to American academy of dermatology, acne which is the most common skin disease affects almost 50 million Americans annually. It was found that at least 85.0% of peoples experience minor acne between the age group 12-24 years. It may occur at any stage of life and may continue in 30’s and 40’s.
In the year 2016 the prevalence of acne vulgaris was around 681.2 million which was 612 million in 2006, which shows that there is 10.0% increase in the prevalence of acne cases. In 2010 acne was ranked as 8th in most frequent diseases in the world with the global prevalence of 645 million.
According to an article published by Indian journal by paediatric dermatology, for a country like India which has more than a billion population there are almost 200-300million acne sufferers.
Hence as the prevalence of acne is increasing year after year, the global topical use acne treatment market is expected to have a pool of opportunities in future.
Rising healthcare expenditures:
According to Statista 2018, the total health care spending for acne treatment in the year 2016 was around 4.2 billion USD. According to American academy of dermatology, in 2013 more than 5.1 million people took medical treatment for acne among which children and young adults were more. In 2013, the costs associated with the treatment and lost productivity among those who sought medical care for acne exceeded 1.2 billion USD. In the US, the cost of acne in terms of treatment and loss of productivity is over 3 billion dollars per year. In 2011, over 19.24% of the total population in the United States was affected with acne.
According to the official U.S., the health care spending in U.S. is greater as compare to any other country in world. In the year 2014 the health care spending in U.S. reached 2.9 trillion USD, which is 17.0% more as compare to U.S. economy. It was found that between 2013-2014 the health care spending was increased by 5.3% and is expected to grow year after year.
Hence with increase in health care expenditure and with increase in cost associated with treatment of acne, the global topical use acne treatment market is expected to grow with a inclining rate in future.
Some of the major market players in this market are GlaxoSmithKline plc, Nestlé Skin Health, ALLERGAN, L’Oréal, Valeant, Johnson & Johnson Private Limited, Cipher Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Bayer AG, Foamix Pharmaceuticals, Dermira, Inc., GUTHYRENKER, Garnier LLC, Beiersdorf, Olay, MIXA, Reckitt Benckiser Group plc.
Table of Contents:
2 MARKET SEGMENTATION
3 MARKET OVERVIEW
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY TYPES OF ACNE
7 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY DRUG
7 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY MEDICATION TYPE
8 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY PRODUCT APPLICATION
9 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY END USER
10 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
11 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, BY COUNTRY
12 GLOBAL TOPICAL USE ACNE TREATMENT MARKET: COMPETITIVE LANDSCAPE
13 GLOBAL TOPICAL USE ACNE TREATMENT MARKET, COMPANY PROFILES
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research
Company Name: Data Bridge Market Research Private Limited
Contact Person: Sopan Gedam
Email: Send Email
Address:Office Number 402, Amanora Chambers, Magarpatta Road, Hadapsar